152 related articles for article (PubMed ID: 36226469)
1. Association between the risk of seizure and COVID-19 vaccinations: A self-controlled case-series study.
Wan EYF; Ng VWS; Chang RS; Yan VKC; Chui CSL; Wong CKH; Li X; Lai FTT; Chan EWY; Hung IFN; Lau KK; Wong ICK
Epilepsia; 2022 Dec; 63(12):3100-3110. PubMed ID: 36226469
[TBL] [Abstract][Full Text] [Related]
2. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
[TBL] [Abstract][Full Text] [Related]
3. Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients.
Wong CKH; Lui DTW; Xiong X; Chui CSL; Lai FTT; Li X; Wan EYF; Cheung CL; Lee CH; Woo YC; Au ICH; Chung MSH; Cheng FWT; Tan KCB; Wong ICK
BMC Med; 2022 Oct; 20(1):339. PubMed ID: 36229814
[TBL] [Abstract][Full Text] [Related]
4. Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study.
Ab Rahman N; Lim MT; Lee FY; Lee SC; Ramli A; Saharudin SN; King TL; Anak Jam EB; Ayub NA; Sevalingam RK; Bahari R; Ibrahim NN; Mahmud F; Sivasampu S; Peariasamy KM;
Vaccine; 2022 Jul; 40(32):4394-4402. PubMed ID: 35667917
[TBL] [Abstract][Full Text] [Related]
5. Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
Wong CKH; Mak LY; Au ICH; Lai FTT; Li X; Wan EYF; Chui CSL; Chan EWY; Cheng WY; Cheng FWT; Yuen MF; Wong ICK
J Hepatol; 2022 Nov; 77(5):1339-1348. PubMed ID: 35817224
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.
Wan EYF; Chui CSL; Wang Y; Ng VWS; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Wong CSM; Leung KSM; Ni MY; Valkenburg SA; Peiris JSM; Wu JTK; Cowling BJ; Ashcroft DM; Hung IFN; Leung GM; Wong ICK
Lancet Reg Health West Pac; 2022 Apr; 21():100393. PubMed ID: 35128500
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong.
Li X; Gao L; Tong X; Chan VKY; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Chan EWY; Lau KK; Lau CS; Wong ICK
J Autoimmun; 2022 Jun; 130():102830. PubMed ID: 35461018
[TBL] [Abstract][Full Text] [Related]
8. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
Wan EYF; Chui CSL; Lai FTT; Chan EWY; Li X; Yan VKC; Gao L; Yu Q; Lam ICH; Chun RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Leung GM; Wong ICK
Lancet Infect Dis; 2022 Jan; 22(1):64-72. PubMed ID: 34411532
[TBL] [Abstract][Full Text] [Related]
9. Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study.
Kang W; Shami JJP; Yan VKC; Ye X; Blais JE; Li X; Lee VHF; Chui CSL; Lai FTT; Wan EYF; Wong CKH; Wong ICK; Chan EW
J Hematol Oncol; 2022 May; 15(1):66. PubMed ID: 35590336
[TBL] [Abstract][Full Text] [Related]
10. Risk of glomerular diseases, proteinuria and hematuria following mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines.
Cheng FWT; Wong CKH; Qin SX; Chui CSL; Lai FTT; Li X; Wan EYF; Chan EW; Au CH; Ye X; Tang SCW; Wong ICK
Nephrol Dial Transplant; 2023 Jan; 38(1):129-137. PubMed ID: 36367015
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study.
Sing CW; Tang CTL; Chui CSL; Fan M; Lai FTT; Li X; Wan EYF; Wong CKH; Chan EWY; Hung IFN; Leung AY; Cheung CL; Wong ICK
Am J Hematol; 2022 Apr; 97(4):470-480. PubMed ID: 35080247
[TBL] [Abstract][Full Text] [Related]
12. Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease.
Ye X; Ma T; Blais JE; Yan VKC; Kang W; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Tse HF; Siu CW; Wong ICK; Chan EW
Cardiovasc Res; 2022 Jul; 118(10):2329-2338. PubMed ID: 35732274
[TBL] [Abstract][Full Text] [Related]
13. mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study.
Wan EYF; Chui CSL; Mok AHY; Xu W; Yan VKC; Lai FTT; Li X; Wong CKH; Chan EWY; Lui DTW; Tan KCB; Hung IFN; Lam CLK; Leung GM; Wong ICK
Drug Saf; 2022 Dec; 45(12):1477-1490. PubMed ID: 36184720
[TBL] [Abstract][Full Text] [Related]
14. Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.
Wong CKH; Xiong X; Lau KTK; Chui CSL; Lai FTT; Li X; Chan EWY; Wan EYF; Au ICH; Cowling BJ; Lee CK; Wong ICK
BMC Med; 2022 Mar; 20(1):119. PubMed ID: 35296305
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
Wan EYF; Mok AHY; Yan VKC; Chan CIY; Wang B; Lai FTT; Chui CSL; Li X; Wong CKH; Lau CS; Wong ICK; Chan EWY
J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36250571
[TBL] [Abstract][Full Text] [Related]
16. Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study.
Wan EYF; Chui CSL; Ng VWS; Wang Y; Yan VKC; Lam ICH; Fan M; Lai FTT; Chan EWY; Li X; Wong CKH; Chung RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Lau CS; Leung GM; Wong ICK
Clin Infect Dis; 2023 Feb; 76(3):e291-e298. PubMed ID: 35675702
[TBL] [Abstract][Full Text] [Related]
17. Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: A self-controlled case series study.
Ye X; Huang C; Wei Y; Li STH; Yan VKC; Yiu KH; Tse HF; Ma T; Qin X; Chui CSL; Lai FTT; Li X; Wan EYF; Wong CKH; Wong ICK; Chan EW
Lancet Reg Health West Pac; 2023 Jan; 30():100630. PubMed ID: 36373159
[TBL] [Abstract][Full Text] [Related]
18. Sex-based differences in risk of ischaemic stroke or systemic embolism after BNT162b2 or CoronaVac COVID-19 vaccination in patients with atrial fibrillation: a self-controlled case series and nested case-control study.
Ye X; Huang C; Yan VKC; Kang W; Fan M; Tsang GKC; Ho CMY; Lip GYH; Yiu KH; Tse HF; Ma T; Qin X; Chui CSL; Lai FTT; Wong CKH; Wan EYF; Li X; Lee CK; Hung IFN; Wong ICK; Chan EWY
Eur Heart J Cardiovasc Pharmacother; 2023 Jul; 9(5):403-412. PubMed ID: 36918200
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months.
Low EV; Tok PSK; Husin M; Suah JL; Tng BH; Thevananthan T; Appannan MR; Yahaya H; Mohd Zin S; Muhamad Zin F; Sivasampu S; Peariasamy KM
JAMA Netw Open; 2022 Aug; 5(8):e2226046. PubMed ID: 35947381
[TBL] [Abstract][Full Text] [Related]
20. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]